EP Patent
EP0462667A2 — Beta-lactams as antihypercholesterolemics
Assigned to Merck and Co Inc · Expires 1991-12-27 · 34y expired
What this patent protects
This application relates to compounds of formula (I), which are useful as antihypercholesterolemic agents. <CHEM>
USPTO Abstract
This application relates to compounds of formula (I), which are useful as antihypercholesterolemic agents. <CHEM>
Drugs covered by this patent
- Zetia (EZETIMIBE) · Merck & Co.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.